You should consider shares of Agilent Technologies Inc. (NYSE:A) and Cardinal Health Inc. (NYSE:CAH) if you are looking for a great stocks to invest in. Starting with the A shares, which traded at $80.10 at the close of the recent session, dropping -0.31%. On Tuesday, the company’s shares shed -$0.25 from its value which represented in intraday trading. The stock is now 10.71% higher in year-to-date (YTD) trading. A’s intraday high was $80.11 while its lowest price touched $79.17. The stock’s 52-week high price is $82.27, which means the current price is at -2.64%. In terms of trading activity, the daily trading volume fell to 1978225 against 200-day average trading volume of 2,252,874 shares.
What are analyst forecasts for Agilent Technologies Inc. (NYSE:A)?
At a consensus rating of 4.25, A is trending as a streaking Moderate Buy, as it has been the case a month ago when 11 analysts called it a Moderate Buy. Two months ago, 11 analysts recommended, on average, that A stock is a Strong Buy. The Healthcare company’s shares’ overall bearish trend saw it close higher on Tuesday compared to its opening price of $79.52 on the day.
Forecasts for Agilent Technologies Inc. (NYSE:A) give the stock a fair value for the growth of 5.76% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $85.00, which means the price per share could rise by nearly $4.9. The price range target is between a low of $76.00 and a high of $93.00. The stock would need to gain by about $13.87 to hit the estimated high or 0.77% from its 12-month low.
The consensus among 15 analysts is that it is a good time for one to Overweight in the Agilent Technologies Inc. 8 analysts rate A as a Buy, with 0 of 15 analysts rate it as a Sell. 1 have valued the stock as Overweight and 5 have recommended that investors Hold.
Agilent Technologies Inc. (NYSE:A) Upgrades and Downgrades
In terms of rating changes, Needham on November 26, 2019, Reiterated Agilent Technologies Inc. (A) at Buy. They believe the stock could reach $85 in the near term. Analysts at Stifel have assigned a Hold rating for the stock in their research note on November 15, 2019. Moreover, UBS analysts issued a rating of Neutral for the stock on October 18, 2019, giving it a price target of $82 for the next 12 months. On July 16, 2019, the stock earned a Neutral rating due to an analyst call from BofA/Merrill, while analysts from Barclays on July 15, 2019 suggested that the stock is Equal Weight.
Cardinal Health Inc. (NYSE:CAH) adds -$0.11 on Tuesday
The CAH stock has risen 22.26% year-to-date and is currently trading at $54.53, which is -4.13% below its 52-week high. The company shares lost -0.20% on the day and have risen nearly 32.90% off a low hit. At current levels, Cardinal Health Inc. has a valuation of about $147.66B. As of 12/03/19, this stock has fallen -3.23% during the week and closed at $54.64 in the previous session. However, recent Cardinal Health Inc. stock performance shows that CAH shares are 8.11% up over the last month, and 22.95% up for the last three months.
Earnings per share (EPS) estimates for the current quarter are $1.09, with the trailing 12-month share earnings at -$14.05. The ratio is expected to be down by -4.50% for the current year 2019 and 4.60% for next year. Over the next 5-year period, earnings per share will be 3.22%. But will the CAH stock surprise in the current quarter results, where the $1.27 actual EPS reported on 9/29/2019 surprised by 16.50% or was higher by $0.18 from the estimated $1.09.
Sales Growth to climb 4.40% for the year
How well will Cardinal Health Inc. perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $39.08B and $39.87B in current quarter sales. The consensus estimated for the current quarter is $39.44B from sales. Forecasts for this fiscal year are between $152.14B and $153.91B and the consensus estimate for sales is at $152.74B.
Who owns shares in Cardinal Health Inc. (CAH)?
Let’s briefly focus on the share ownership of the Cardinal Health Inc. (NYSE:CAH) stock, where we find that 92.36% of shares are held by institutions. Vanguard Group, Inc. (The) tops the list of institutional owners as it is holding 36.49 million shares or 12.47% of shares outstanding. Blackrock Inc. and State Street Corporation held 22.12 million and 21.78 million representing 7.56% and 7.45% respectively at the close of the last trading session. As of Sep 29, 2019, Macquarie Group Limited accounted for 15.5 million shares at over 731.58 million. This represented 5.30% of shares outstanding. Invesco Ltd. held 9.29 million shares at over 438.23 million representing 3.18% of shares outstanding.
CAH Insider Activity
On 8/15/2019, Chief Executive & Financial Officer by the name Kaufmann Michael C sold 10660.0 shares worth $452100.0 at the price of $42.41 per share. Filings also show that Kaufmann Michael C sold a total of 6638.0 shares on 11/08/2019 valued at $353100.0. Since the last insider activity, the company’s share price has climbed 1.45%.